Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor (Q34484174)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor |
scientific article |
Statements
1 reference
Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor (English)
1 reference
Keith T Flaherty
1 reference
Mario Sznol
1 reference
Jeffrey S Weber
1 reference
Jeffrey A Sosman
1 reference
Nageatte Ibrahim
1 reference
Omid Hamid
1 reference
Lynn Schuchter
1 reference
Jonathan Cebon
1 reference
Howard A Burris
1 reference
Gerald S Falchook
1 reference
Alain Algazi
1 reference
Shonda Little
1 reference
Kiran Patel
1 reference
Jeffrey R Infante
1 reference
William H Sharfman
1 reference
Robert R McWilliams
1 reference
Douglas B Johnson
1 reference
Kevin B Kim
1 reference
Donald P Lawrence
1 reference
Geoffrey T Gibney
1 reference
Karl Lewis
1 reference
Peng Sun
1 reference
Elizabeth Cunningham
1 reference
Rene Gonzalez
1 reference
6 October 2014
1 reference
1 reference
32
1 reference
33
1 reference
3697-3704
1 reference
Identifiers
1 reference
1 reference
1 reference